These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10614909)

  • 1. The immunogenetics of thyroid-associated orbitopathy.
    Weetman AP; Hunt PJ
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S149-51. PubMed ID: 10614909
    [No Abstract]   [Full Text] [Related]  

  • 2. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy.
    Buzzetti R; Nisticò L; Signore A; Cascino I
    Lancet; 1999 Nov; 354(9192):1824. PubMed ID: 10577673
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.
    Vaidya B; Imrie H; Perros P; Dickinson J; McCarthy MI; Kendall-Taylor P; Pearce SH
    Lancet; 1999 Aug; 354(9180):743-4. PubMed ID: 10475192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic determinants of Graves disease.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Nosikov VV
    Mol Genet Metab; 2000; 71(1-2):66-9. PubMed ID: 11001797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity in thyroid disease.
    Collins J; Gough S
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S417-24. PubMed ID: 12192541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aetiology of Graves' disease: what is the genetic contribution?
    Philippou G; McGregor AM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):393-5. PubMed ID: 9640403
    [No Abstract]   [Full Text] [Related]  

  • 7. The genetics of Graves' disease.
    Gough SC
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):255-66. PubMed ID: 10874528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
    Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
    Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of linkage and association between autoimmune thyroid diseases and the CTLA-4 gene in a large Tunisian family.
    Maalej A; Bougacha N; Rebai A; Bellassouad M; Ayadi-Makni F; Abid M; Jouida J; Makni H; Ayadi H
    Hum Immunol; 2001 Nov; 62(11):1245-50. PubMed ID: 11704287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of autoimmune thyroid disease.
    Vaidya B; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5385-97. PubMed ID: 12466323
    [No Abstract]   [Full Text] [Related]  

  • 12. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
    Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
    Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
    Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
    Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Mse I RFLP in the human CTLA4 promotor.
    Deichmann K; Heinzmann A; Brüggenolte E; Forster J; Kuehr J
    Biochem Biophys Res Commun; 1996 Aug; 225(3):817-8. PubMed ID: 8780695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic dissection of familial autoimmune thyroid diseases using whole genome screening.
    Tomer Y
    Autoimmun Rev; 2002 Aug; 1(4):198-204. PubMed ID: 12848996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage.
    Tomer Y
    Thyroid; 2001 Feb; 11(2):167-9. PubMed ID: 11288987
    [No Abstract]   [Full Text] [Related]  

  • 17. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.
    Vaidya B; Imrie H; Perros P; Young ET; Kelly WF; Carr D; Large DM; Toft AD; McCarthy MI; Kendall-Taylor P; Pearce SH
    Hum Mol Genet; 1999 Jul; 8(7):1195-9. PubMed ID: 10369864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex association analysis of graves disease using a set of polymorphic markers.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Petunina NA; Trukhina LV; Kudinova AV; Balabolkin MI; Nosikov VV
    Mol Genet Metab; 2000 Jul; 70(3):214-8. PubMed ID: 10924276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A linkage study of cytotoxic T lymphocyte-associated antigen 4 gene and Graves' disease in northern Chinese Han ethnic].
    Jin Y; Ben S; Teng W; Zhang J; Xiong X; Zhao Y; Huang W
    Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):809-12. PubMed ID: 12654233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-tuning of T lymphocytes in autoimmunity: genetic association of CTLA-4 variants and Graves' disease revisited.
    Badenhoop K; Seidl C
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):555-7. PubMed ID: 14616877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.